Susquehanna Fundamental Investments, LLC Pacific Biosciences Of California, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $232,330 - $576,004	-27,560 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $300,436 - $469,217	-15,599 Reduced 36.14%	27,560 $564,000
Q3 2021 Nov 15, 2021	SELL	$24.86 - $35.02 $1.02 Million - $1.44 Million	-41,220 Reduced 48.85%	43,159 $1.1 Million
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $709,140 - $1.15 Million	-31,800 Reduced 27.37%	84,379 $2.95 Million
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $151,189 - $410,371	14,399 Added 14.15%	116,179 $3.01 Million
Q3 2020 Nov 16, 2020	BUY	$3.61 - $9.87 $58,770 - $160,683	16,280 Added 19.04%	101,780 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$2.65 - $4.03 $226,575 - $344,565	85,500 New	85,500 $295,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.